§ Results from the CORAL Trial are now available.at http://www.nejm.org/doi/full/10.1056/NEJMoa1310753 § The CORAL trial was designed to test whether renal-artery stenting, when added to protocoldriven contemporary medical therapy, improves clinical outcomes in persons with atherosclerotic renal-artery stenosis. § The investigators "found no benefit of stenting with respect to the rate of the composite primary end point or any of its individual components, including death from cardiovascular or renal causes, stroke, myocardial infarction, congestive heart failure, progressive renal insufficiency, and the need for renal-replacement therapy." § Now that the results from the CORAL trial are available, an update to the AHRQ comparative effectiveness review, which incorporates findings from this trial, is warranted. 
